Indication

Adrenal cortex carcinoma

Adrenal cortex carcinoma, commonly referred to as adrenocortical carcinoma, is a rare and aggressive endocrine malignancy originating in the outer layer of the adrenal gland. Read more about Adrenal cortex carcinoma

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Adrenal cortex carcinoma therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Adrenal cortex carcinoma preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Adrenal cortex carcinoma.

Adrenal cortex carcinoma, commonly referred to as adrenocortical carcinoma, is a rare and aggressive endocrine malignancy originating in the outer layer of the adrenal gland.

It can affect both pediatric and adult populations, often exhibiting a bimodal age distribution peaking in early childhood and again in the fourth to fifth decades of life.

Pathophysiologically, the tumor arises from steroidogenic adrenocortical cells and may present as nonfunctional or functional.

Functional tumors hypersecrete adrenal steroids—most commonly cortisol, androgens, or aldosterone—leading to endocrine syndromes such as Cushing syndrome, virilization, or refractory hypertension.

Nonfunctional variants typically manifest late with abdominal mass effect, localized pain, or incidental retroperitoneal imaging findings, and carry a pronounced risk of local invasion and distant metastasis.

Personalize your experience

Follow Adrenal cortex carcinoma and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it